The 2nd annual Asia Biotech Invest conference was a great success!
Hong Kong’s biggest biotech showcase and deal-making event, organised by AusBiotech and Beacon Events on 4-5 June, welcomed over 220 senior level delegates from the life science community. On both conference days the conference room and exhibition area was buzzing with excitement and everyone made full use of the networking opportunities. With over 140 confirmed 1-on-1 meetings the BioInvest Partnering system also proved to be a valuable networking tool.
Delegates benefited from lively panel discussions and keynotes by leading investors, industry advisors, biotech CEOs and big pharma representatives on such topics as:
– Global and regional biotech investment trends
– Strategies for international partnering and licensing
– Market access and pricing strategies
– Analyst perspectives on the biotech boom
– Healthcare investment and partnering in Greater China
Plus, 28 pioneering biotech companies from across the globe presented their pipelines and investment cases in 8-minute pitches to the attentive investor audience.
Here is what the delegates said about Asia Biotech Invest 2014:
“My congratulations to AusBiotech and Beacon Events, co-organisers of the Asia Biotech Invest 2014 conference, for an interesting, informative and stimulating meeting. As a relative newcomer to the field I learned much from the wide variety of biotech investment experts and innovators present, all of whom were glad to share their knowledge and experience. I am pleased to have participated in a worthwhile event.”
Eugene Salole PhD MPH, Principal, Value-Based Access (Australia)
“This is the second Asia Biotech Invest conference I have attended and it is clear the level of interest across the investment community towards the life science sector is growing. The quality of presentations and insights into emerging companies will continue to attract investors. Well done.”
Scott Power, Senior Analyst Healthcare & Biotechnology, Morgans (Australia)
“Asia Biotech Invest is a great conference for investors and companies to learn about the biotech landscape in Asia. The conference brings together some of the leading figures in biotech in the region, from marquee investors to innovative companies.”
Dr Eric Shiozaki, Principal, Novo A/S (United States)
“I found the meeting both informative and interactive to discuss the biopharma industry and investment opportunities in Asia. The size of the event is adequate to allow good interactions among attendees.”
Dr Darren Ji, Global Head of Roche Partnering, Asia and Emerging Markets, Roche (China)
… and many more. Click here to see other testimonials from our delegates.
Click here to view the event photos
Mark your calendar for the upcoming Biotech Invest events:
For enquiries on how you can participate in the Biotech Invest series, please contact us on:
Tel: +613 9828 1400
|Rest of the World:
Tel: +852 2531 6125